-+ 0.00%
-+ 0.00%
-+ 0.00%

NervGen Pharma Announces Breakthrough Phase 1b/2a Trial Results for NVG-291, Paving Way for Expedited Approval Discussions

Reuters·08/26/2025 11:31:18

Please log in to view news